HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Epidemiological studies of styrene-exposed populations.

AbstractThe potential human carcinogenicity of styrene has been investigated mainly by epidemiological studies of occupationally exposed populations. Several cohort studies have suggested that workers exposed to styrene in the chemical industry have increased mortality from lymphatic and hematopoietic cancer. However, this finding has not been consistent and has not been reproduced in studies of reinforced plastics manufacturers, whose exposures to styrene are generally higher. The explanation for the observed associations may therefore be confounding by concomitant exposures to other chemicals such as benzene and butadiene, which are not used in the reinforced plastics industry. Despite their large size, the published studies of mortality and cancer incidence lack the statistical power to rule out an important hazard from long-term exposure to high (> 50 ppm) airborne concentrations of styrene. However, they indicate that any risk of cancer from lower levels of exposure is likely to be small.
AuthorsD Coggon (Affiliation: MRC Environmental Epidemiology Unit, Southampton General Hospital, U.K.)
JournalCritical reviews in toxicology (Crit Rev Toxicol) Vol. 24 Suppl Pg. S107-15 ( 1994) ISSN: 1040-8444 [Print] UNITED STATES
PMID7818767 (Publication Type: Journal Article, Review)
Chemical References
  • Styrenes
  • Styrene
Topics
  • Humans
  • Leukemia (chemically induced, epidemiology)
  • Lymphoma (chemically induced, epidemiology)
  • Neoplasms (chemically induced, epidemiology, mortality)
  • Occupational Exposure (adverse effects)
  • Styrene
  • Styrenes (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD